Screening compound: HNUDLPVNRRRPIT-QGZVFWFLSA-N

Screening compound: HNUDLPVNRRRPIT-QGZVFWFLSA-N
Screening compound: HNUDLPVNRRRPIT-QGZVFWFLSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
HNUDLPVNRRRPIT-QGZVFWFLSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M284-0899

Molecular Formula

C21H20FN3O4 (C21 H20 FN3 O4)

Compound Name

2-[8-fluoro-5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]-N~1~-(4-methoxyphenyl)acetamide

IUPAC name

2-{12-fluoro-28-dioxo-39-diazatricyclo[8.4.0.0^{37}]tetradeca-1(14)1012-trien-9-yl}-N-(4-methoxyphenyl)acetamide

SMILES

COc(cc1)ccc1NC(CN(c(cc(cc1)F)c1C(N1C2CCC1)=O)C2=O)=O

InChI

InChI=1S/C21H20FN3O4/c1-29-15-7-5-14(6-8-15)23-19(26)12-25-18-11-13(22)4-9-16(18)20(27)24-10-2-3-17(24)21(25)28/h4-9,11,17H,2-3,10,12H2,1H3,(H,23,26)/t17-/m1/s1

InChI Key

HNUDLPVNRRRPIT-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD27535090

HNUDLPVNRRRPIT-QGZVFWFLSA-N in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with HNUDLPVNRRRPIT-QGZVFWFLSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound HNUDLPVNRRRPIT-QGZVFWFLSA-N?
Check Price and Availability of HNUDLPVNRRRPIT-QGZVFWFLSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of HNUDLPVNRRRPIT-QGZVFWFLSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for HNUDLPVNRRRPIT-QGZVFWFLSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for HNUDLPVNRRRPIT-QGZVFWFLSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of HNUDLPVNRRRPIT-QGZVFWFLSA-N available by request